BSE Live
Jan 21, 13:51Prev. Close
824.05
Open Price
819.00
Bid Price (Qty.)
832.40 (61)
Offer Price (Qty.)
833.75 (153)
NSE Live
Jan 21, 13:51Prev. Close
822.75
Open Price
819.95
Bid Price (Qty.)
832.95 (1)
Offer Price (Qty.)
833.35 (7)
| Key Financial Ratios of Natco Pharma (in Rs. Cr.) | Mar 05 | Mar 04 | |
| Per Share Ratios | |||
| Basic EPS (Rs.) | 0.60 | 3.73 | |
| Diluted EPS (Rs.) | 0.60 | 3.73 | |
| Cash EPS (Rs.) | 5.63 | 7.36 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 43.44 | 33.09 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 43.44 | 38.06 | |
| Dividend / Share(Rs.) | 0.00 | 0.00 | |
| Revenue from Operations/Share (Rs.) | 63.45 | 59.44 | |
| PBDIT/Share (Rs.) | 6.74 | 11.41 | |
| PBIT/Share (Rs.) | 4.51 | 9.38 | |
| PBT/Share (Rs.) | -0.28 | 3.85 | |
| Net Profit/Share (Rs.) | 0.60 | 3.73 | |
| Profitability Ratios | |||
| PBDIT Margin (%) | 10.62 | 19.20 | |
| PBIT Margin (%) | 7.10 | 15.77 | |
| PBT Margin (%) | -0.44 | 6.47 | |
| Net Profit Margin (%) | 0.93 | 6.26 | |
| Return on Networth / Equity (%) | 1.36 | 11.25 | |
| Return on Capital Employed (%) | 0.80 | 5.72 | |
| Return on Assets (%) | 0.53 | 3.52 | |
| Total Debt/Equity (X) | 0.98 | 1.36 | |
| Asset Turnover Ratio (%) | 56.95 | 56.24 | |
| Liquidity Ratios | |||
| Current Ratio (X) | 1.66 | 1.33 | |
| Quick Ratio (X) | 1.27 | 0.93 | |
| Inventory Turnover Ratio (X) | 4.37 | 3.70 | |
| Dividend Payout Ratio (NP) (%) | 0.00 | 0.00 | |
| Dividend Payout Ratio (CP) (%) | 0.00 | 0.00 | |
| Earnings Retention Ratio (%) | 100.00 | 0.00 | |
| Cash Earnings Retention Ratio (%) | 100.00 | 0.00 | |
| Valuation Ratios | |||
| Enterprise Value (Cr.) | 401.47 | 319.00 | |
| EV/Net Operating Revenue (X) | 2.42 | 2.30 | |
| EV/EBITDA (X) | 22.77 | 11.95 | |
| MarketCap/Net Operating Revenue (X) | 2.03 | 1.56 | |
| Retention Ratios (%) | 100.00 | 0.00 | |
| Price/BV (X) | 2.96 | 2.80 | |
| Price/Net Operating Revenue | 2.03 | 1.56 | |
| Earnings Yield | 0.00 | 0.04 |
26.11.2025
Natco Pharma Consolidated September 2025 Net Sales at Rs 1,363.00 crore, down 0.59% Y-o-Y
24.11.2025
Natco Pharma Standalone September 2025 Net Sales at Rs 1,264.30 crore, down 2.19% Y-o-Y
24.11.2025
24.11.2025
26.11.2025
Natco Pharma Consolidated September 2025 Net Sales at Rs 1,363.00 crore, down 0.59% Y-o-Y
24.11.2025
Natco Pharma Standalone September 2025 Net Sales at Rs 1,264.30 crore, down 2.19% Y-o-Y
14.11.2025
Natco Pharma Consolidated September 2025 Net Sales at Rs 1,363.00 crore, down 0.59% Y-o-Y
09.09.2025
Natco Pharma Standalone June 2025 Net Sales at Rs 1,192.70 crore, down 3.57% Y-o-Y